{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:44:50Z","timestamp":1786981490919,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T00:00:00Z","timestamp":1462320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007311","name":"Deutsche Kinderkrebsstiftung","doi-asserted-by":"publisher","award":["DKS 99.02"],"award-info":[{"award-number":["DKS 99.02"]}],"id":[{"id":"10.13039\/501100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007311","name":"Deutsche Kinderkrebsstiftung","doi-asserted-by":"publisher","award":["DKS 2002.0.4"],"award-info":[{"award-number":["DKS 2002.0.4"]}],"id":[{"id":"10.13039\/501100007311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s11060-016-2133-x","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T02:25:02Z","timestamp":1462328702000},"page":"463-471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors"],"prefix":"10.1007","volume":"128","author":[{"given":"Kristian W.","family":"Pajtler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Tippelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Siegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Reichling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Mikasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Gnekow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Pietsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Benesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Fleischhack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,4]]},"reference":[{"issue":"Suppl 4","key":"2133_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol 16(Suppl 4):iv1\u2013iv63. doi: 10.1093\/neuonc\/nou223","journal-title":"Neuro Oncol"},{"key":"2133_CR2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/pbc.20212","volume":"45","author":"FY Agaoglu","year":"2005","unstructured":"Agaoglu FY, Ayan I, Dizdar Y, Kebudi R, Gorgun O, Darendeliler E (2005) Ependymal tumors in childhood. Pediatr Blood Cancer 45:298\u2013303","journal-title":"Pediatr Blood Cancer"},{"key":"2133_CR3","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.ejca.2009.01.015","volume":"45","author":"K Hoff von","year":"2009","unstructured":"von Hoff K, Hinkes B, Gerber NU, Deinlein F, Mittler U, Urban C, Benesch M, Warmuth-Metz M, Soerensen N, Zwiener I, Goette H, Schlegel PG, Pietsch T, Kortmann RD, Kuehl J, Rutkowski S (2009) Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT\u201991. Eur J Cancer 45:1209\u20131217. doi: 10.1016\/j.ejca.2009.01.015","journal-title":"Eur J Cancer"},{"key":"2133_CR4","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1002\/cncr.28907","volume":"120","author":"C Wetmore","year":"2014","unstructured":"Wetmore C, Herington D, Lin T, Onar-Thomas A, Gajjar A, Merchant TE (2014) Reirradiation of recurrent medulloblastoma: does clinical benefit outweigh risk for toxicity? Cancer 120:3731\u20133737. doi: 10.1002\/cncr.28907","journal-title":"Cancer"},{"key":"2133_CR5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000121037","volume":"24","author":"GS Baumann","year":"1996","unstructured":"Baumann GS, Wara WM, Larson DA, Sneed PK, Gutin PH, Ciricillo SF, McDermott MW, Park E, Stalpers LJ, Verhey LJ, Smith V, Petti PL, Edwards MS (1996) Gamma knife radiosurgery in children. Pediatr Neurosurg 24:193\u2013201","journal-title":"Pediatr Neurosurg"},{"key":"2133_CR6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1201\/b13511-18","volume-title":"Brain and spinal tumors of childhood","author":"SM Blaney","year":"2004","unstructured":"Blaney SM, Berg SL, Boddy AV (2004) Drug delivery. In: Walker DA, Perilongo G, Punt JAG, Taylor RE (eds) Brain and spinal tumors of childhood. Arnold, London, pp 228\u2013242"},{"key":"2133_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-200544010-00001","volume":"44","author":"G Fleischhack","year":"2005","unstructured":"Fleischhack G, Jaehde U, Bode U (2005) Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis. Clin Pharmacokinet 44:1\u201331. doi: 10.2165\/00003088-200544010-00001","journal-title":"Clin Pharmacokinet"},{"key":"2133_CR8","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1056\/NEJMoa042176","volume":"352","author":"S Rutkowski","year":"2005","unstructured":"Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, Kortmann RD, Kuehl J (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352:978\u2013986. doi: 10.1056\/NEJMoa042176","journal-title":"N Engl J Med"},{"key":"2133_CR9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00043426-200205000-00011","volume":"24","author":"PG Fisher","year":"2002","unstructured":"Fisher PG, Kadan-Lottick NS, Korones DN (2002) Intrathecal thiotepa: reappraisal of an established therapy. J Pediatr Hematol Oncol 24:274\u2013278","journal-title":"J Pediatr Hematol Oncol"},{"key":"2133_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11060-006-9327-6","volume":"83","author":"A Lassaletta","year":"2007","unstructured":"Lassaletta A, Perez-Olleros P, Scaglione C, Sirvent S, De Prada I, Perez-Martinez A, Ruiz-Hernandez A, Madero L (2007) Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child. J Neuro Oncol 83:303\u2013306. doi: 10.1007\/s11060-006-9327-6","journal-title":"J Neuro Oncol"},{"key":"2133_CR11","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1200\/JCO.2004.01.046","volume":"22","author":"L Bomgaars","year":"2004","unstructured":"Bomgaars L, Geyer JR, Franklin J, Dahl G, Park J, Winick NJ, Klenke R, Berg SL, Blaney SM (2004) Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis. J Clin Oncol 22:3916\u20133921. doi: 10.1200\/JCO.2004.01.046","journal-title":"J Clin Oncol"},{"key":"2133_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/neuonc\/nor025","volume":"13","author":"AO Bueren von","year":"2011","unstructured":"von Bueren AO, von Hoff K, Pietsch T, Gerber NU, Warmuth-Metz M, Deinlein F, Zwiener I, Faldum A, Fleischhack G, Benesch M, Krauss J, Kuehl J, Kortmann RD, Rutkowski S (2011) Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro Oncol 13:669\u2013679. doi: 10.1093\/neuonc\/nor025","journal-title":"Neuro Oncol"},{"key":"2133_CR13","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1016\/j.ejca.2015.08.009","volume":"51","author":"RS Pompe","year":"2015","unstructured":"Pompe RS, von Bueren AO, Mynarek M, von Hoff K, Friedrich C, Kwiecien R, Treulieb W, Lindow C, Deinlein F, Fleischhack G, Kuehl J, Rutkowski S (2015) Intraventricular methotrexate as part of primary therapy for children with infant and\/or metastatic medulloblastoma: feasibility, acute toxicity and evidence for efficacy. Eur J Cancer 51:2634\u20132642. doi: 10.1016\/j.ejca.2015.08.009","journal-title":"Eur J Cancer"},{"key":"2133_CR14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/1097-0142(197502)35:2<291::AID-CNCR2820350202>3.0.CO;2-V","volume":"35","author":"LJ Rubinstein","year":"1975","unstructured":"Rubinstein LJ, Herman MM, Long TF, Wilbur JR (1975) Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer 35:291\u2013305","journal-title":"Cancer"},{"key":"2133_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40262-013-0106-1","volume":"53","author":"A Peyrl","year":"2014","unstructured":"Peyrl A, Sauermann R, Chocholous M, Azizi AA, Jager W, Hoferl M, Slavc I (2014) Pharmacokinetics and toxicity of intrathecal liposomal cytarabine in children and adolescents following age-adapted dosing. Clin Pharmacokinet 53:165\u2013173. doi: 10.1007\/s40262-013-0106-1","journal-title":"Clin Pharmacokinet"},{"key":"2133_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11060-009-9892-6","volume":"95","author":"A Lassaletta","year":"2009","unstructured":"Lassaletta A, Lopez-Ibor B, Mateos E, Gonzalez-Vicent M, Perez-Martinez A, Sevilla J, Diaz MA, Madero L (2009) Intrathecal liposomal cytarabine in children under 4\u00a0years with malignant brain tumors. J Neuro Oncol 95:65\u201369. doi: 10.1007\/s11060-009-9892-6","journal-title":"J Neuro Oncol"},{"key":"2133_CR17","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/CAD.0b013e32832f4abe","volume":"20","author":"M Benesch","year":"2009","unstructured":"Benesch M, Siegler N, Hoff K, Lassay L, Kropshofer G, Muller H, Sommer C, Rutkowski S, Fleischhack G, Urban C (2009) Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study. Anticancer Drugs 20:794\u2013799. doi: 10.1097\/CAD.0b013e32832f4abe","journal-title":"Anticancer Drugs"},{"key":"2133_CR18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0887-8994(97)00098-2","volume":"17","author":"MC Chamberlain","year":"1997","unstructured":"Chamberlain MC, Kormanik PA (1997) Chronic oral VP-16 for recurrent medulloblastoma. Pediatr Neurol 17:230\u2013234","journal-title":"Pediatr Neurol"},{"key":"2133_CR19","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.1996.14.6.1922","volume":"14","author":"DM Ashley","year":"1996","unstructured":"Ashley DM, Meier L, Kerby T, Zalduondo FM, Friedman HS, Gajjar A, Kun L, Duffner PK, Smith S, Longee D (1996) Response of recurrent medulloblastoma to low-dose oral etoposide. J Clin Oncol 14:1922\u20131927","journal-title":"J Clin Oncol"},{"key":"2133_CR20","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1054\/bjoc.2001.1841","volume":"84","author":"G Fleischhack","year":"2001","unstructured":"Fleischhack G, Reif S, Hasan C, Jaehde U, Hettmer S, Bode U (2001) Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours. Br J Cancer 84:1453\u20131459. doi: 10.1054\/bjoc.2001.1841","journal-title":"Br J Cancer"},{"key":"2133_CR21","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1148\/93.6.1351","volume":"93","author":"CH Chang","year":"1969","unstructured":"Chang CH, Housepian EM, Herbert C Jr (1969) An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93:1351\u20131359","journal-title":"Radiology"},{"key":"2133_CR22","doi-asserted-by":"crossref","first-page":"606","DOI":"10.5414\/CPP41606","volume":"41","author":"C Sirisangtragul","year":"2003","unstructured":"Sirisangtragul C, Henke G, Fleischhack G, Reif S, Kloft C, Bode U, Jaehde U (2003) Cerebrospinal fluid pharmacokinetics after different dosage regimens of intraventricular etoposide. Int J Clin Pharmacol Ther 41:606\u2013607","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2133_CR23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1750-3639.1993.tb00752.x","volume":"3","author":"P Kleihues","year":"1993","unstructured":"Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3:255\u2013268","journal-title":"Brain Pathol"},{"key":"2133_CR24","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1002\/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F","volume":"88","author":"P Kleihues","year":"2000","unstructured":"Kleihues P, Sobin LH (2000) World Health Organization classification of tumors. Cancer 88:2887","journal-title":"Cancer"},{"key":"2133_CR25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"DR Macdonald","year":"1990","unstructured":"Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277\u20131280","journal-title":"J Clin Oncol"},{"key":"2133_CR26","volume-title":"Common terminology criteria for adverse events v4.0","author":"NCI","year":"2009","unstructured":"NCI (2009) Common terminology criteria for adverse events v4.0. NCI, NIH, DHHS, Bethesda"},{"key":"2133_CR27","volume-title":"WHO handbook for reporting results of cancer treatment","author":"WHO","year":"1979","unstructured":"WHO (1979) WHO handbook for reporting results of cancer treatment. WHO, Geneva"},{"key":"2133_CR28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1025633704071","volume":"64","author":"I Slavc","year":"2003","unstructured":"Slavc I, Schuller E, Falger J, Gunes M, Pillwein K, Czech T, Dietrich W, Rossler K, Dieckmann K, Prayer D, Hainfellner J (2003) Feasibility of long-term intraventricular therapy with mafosfamide (n\u00a0=\u00a026) and etoposide (n\u00a0=\u00a011): experience in 26 children with disseminated malignant brain tumors. J Neuro Oncol 64:239\u2013247","journal-title":"J Neuro Oncol"},{"key":"2133_CR29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00685957","volume":"29","author":"A Gaast van der","year":"1992","unstructured":"van der Gaast A, Sonneveld P, Mans DR, Splinter TA (1992) Intrathecal administration of etoposide in the treatment of malignant meningitis: feasibility and pharmacokinetic data. Cancer Chemother Pharmacol 29:335\u2013337","journal-title":"Cancer Chemother Pharmacol"},{"key":"2133_CR30","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1200\/JCO.2003.04.056","volume":"21","author":"H Pels","year":"2003","unstructured":"Pels H, Schmidt-Wolf IG, Glasmacher A, Schulz H, Engert A, Diehl V, Zellner A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Deckert M, Fimmers R, Helmstaedter C, Atasoy A, Klockgether T, Schlegel U (2003) Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 21:4489\u20134495. doi: 10.1200\/JCO.2003.04.056","journal-title":"J Clin Oncol"},{"key":"2133_CR31","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/cncr.21828","volume":"106","author":"MC Chamberlain","year":"2006","unstructured":"Chamberlain MC, Tsao-Wei DD, Groshen S (2006) Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis. Cancer 106:2021\u20132027. doi: 10.1002\/cncr.21828","journal-title":"Cancer"},{"key":"2133_CR32","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","volume":"17","author":"MJ Glantz","year":"1999","unstructured":"Glantz MJ, LaFollette S, Jaeckle KA, Shapiro W, Swinnen L, Rozental JR, Phuphanich S, Rogers LR, Gutheil JC, Batchelor T, Lyter D, Chamberlain M, Maria BL, Schiffer C, Bashir R, Thomas D, Cowens W, Howell SB (1999) Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 17:3110\u20133116","journal-title":"J Clin Oncol"},{"key":"2133_CR33","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/cncr.24150","volume":"115","author":"S Puget","year":"2009","unstructured":"Puget S, Boddaert N, Viguier D, Kieffer V, Bulteau C, Garnett M, Callu D, Sainte-Rose C, Kalifa C, Dellatolas G, Grill J (2009) Injuries to inferior vermis and dentate nuclei predict poor neurological and neuropsychological outcome in children with malignant posterior fossa tumors. Cancer 115:1338\u20131347. doi: 10.1002\/cncr.24150","journal-title":"Cancer"},{"key":"2133_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejpn.2009.10.005","volume":"14","author":"PK Duffner","year":"2010","unstructured":"Duffner PK (2010) Risk factors for cognitive decline in children treated for brain tumors. Eur J Paediatr Neurol 14:106\u2013115. doi: 10.1016\/j.ejpn.2009.10.005","journal-title":"Eur J Paediatr Neurol"},{"key":"2133_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11060-009-9927-z","volume":"95","author":"P Frange","year":"2009","unstructured":"Frange P, Alapetite C, Gaboriaud G, Bours D, Zucker JM, Zerah M, Brisse H, Chevignard M, Mosseri V, Bouffet E, Doz F (2009) From childhood to adulthood: long-term outcome of medulloblastoma patients. The Institut Curie experience (1980\u20132000). J Neuro Oncol 95:271\u2013279. doi: 10.1007\/s11060-009-9927-z","journal-title":"J Neuro Oncol"},{"key":"2133_CR36","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/jnci\/djq238","volume":"102","author":"DL Friedman","year":"2010","unstructured":"Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP (2010) Subsequent neoplasms in 5-year survivors of childhood cancer: the childhood cancer survivor study. J Natl Cancer Inst 102:1083\u20131095. doi: 10.1093\/jnci\/djq238","journal-title":"J Natl Cancer Inst"},{"key":"2133_CR37","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.3390\/ijerph9062075","volume":"9","author":"IG Cowell","year":"2012","unstructured":"Cowell IG, Austin CA (2012) Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents. Intern J Environ Res Public Health 9:2075\u20132091. doi: 10.3390\/ijerph9062075","journal-title":"Intern J Environ Res Public Health"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2133-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-016-2133-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2133-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:23:01Z","timestamp":1559348581000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-016-2133-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,4]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["2133"],"URL":"https:\/\/doi.org\/10.1007\/s11060-016-2133-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,4]]}}}